These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 22469639

  • 1. Cardiovascular disease and nonalcoholic fatty liver disease: does histologic severity matter?
    Domanski JP, Park SJ, Harrison SA.
    J Clin Gastroenterol; 2012; 46(5):427-30. PubMed ID: 22469639
    [Abstract] [Full Text] [Related]

  • 2. Nonalcoholic fatty liver disease in severely obese subjects.
    Gholam PM, Flancbaum L, Machan JT, Charney DA, Kotler DP.
    Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
    [Abstract] [Full Text] [Related]

  • 3. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.
    Bhagat V, Mindikoglu AL, Nudo CG, Schiff ER, Tzakis A, Regev A.
    Liver Transpl; 2009 Dec; 15(12):1814-20. PubMed ID: 19938128
    [Abstract] [Full Text] [Related]

  • 4. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, Goodman Z, Younossi ZM.
    Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
    [Abstract] [Full Text] [Related]

  • 5. Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass.
    Boza C, Riquelme A, Ibañez L, Duarte I, Norero E, Viviani P, Soza A, Fernandez JI, Raddatz A, Guzman S, Arrese M.
    Obes Surg; 2005 Sep; 15(8):1148-53. PubMed ID: 16197788
    [Abstract] [Full Text] [Related]

  • 6. Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression.
    Ekstedt M, Franzén LE, Mathiesen UL, Kechagias S.
    Scand J Gastroenterol; 2012 Jan; 47(1):108-15. PubMed ID: 22126450
    [Abstract] [Full Text] [Related]

  • 7. Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events.
    Vanwagner LB, Bhave M, Te HS, Feinglass J, Alvarez L, Rinella ME.
    Hepatology; 2012 Nov; 56(5):1741-50. PubMed ID: 22611040
    [Abstract] [Full Text] [Related]

  • 8. The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients.
    Shalhub S, Parsee A, Gallagher SF, Haines KL, Willkomm C, Brantley SG, Pinkas H, Saff-Koche L, Murr MM.
    Obes Surg; 2004 Jan; 14(1):54-9. PubMed ID: 14980034
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
    Prashanth M, Ganesh HK, Vima MV, John M, Bandgar T, Joshi SR, Shah SR, Rathi PM, Joshi AS, Thakkar H, Menon PS, Shah NS.
    J Assoc Physicians India; 2009 Mar; 57():205-10. PubMed ID: 19588648
    [Abstract] [Full Text] [Related]

  • 10. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
    Salomao M, Yu WM, Brown RS, Emond JC, Lefkowitch JH.
    Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
    [Abstract] [Full Text] [Related]

  • 11. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease.
    Yalamanchili K, Saadeh S, Klintmalm GB, Jennings LW, Davis GL.
    Liver Transpl; 2010 Apr; 16(4):431-9. PubMed ID: 20373454
    [Abstract] [Full Text] [Related]

  • 12. Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver disease.
    Papatheodoridis GV, Chrysanthos N, Cholongitas E, Pavlou E, Apergis G, Tiniakos DG, Andrioti E, Theodossiades G, Archimandritis AJ.
    J Hepatol; 2009 Nov; 51(5):931-8. PubMed ID: 19726097
    [Abstract] [Full Text] [Related]

  • 13. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease.
    Abrams GA, Kunde SS, Lazenby AJ, Clements RH.
    Hepatology; 2004 Aug; 40(2):475-83. PubMed ID: 15368453
    [Abstract] [Full Text] [Related]

  • 14. [Epidemiology and natural history of nonalcoholic fatty liver disease].
    Pais R, Ratziu V.
    Rev Prat; 2012 Dec; 62(10):1416-8, 1420-1. PubMed ID: 23424924
    [Abstract] [Full Text] [Related]

  • 15. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study.
    Harrison SA, Torgerson S, Hayashi PH.
    Am J Gastroenterol; 2003 Sep; 98(9):2042-7. PubMed ID: 14499785
    [Abstract] [Full Text] [Related]

  • 16. Noninvasive assessment of nonalcoholic fatty liver disease in obese or overweight patients.
    Francque SM, Verrijken A, Mertens I, Hubens G, Van Marck E, Pelckmans P, Michielsen P, Van Gaal L.
    Clin Gastroenterol Hepatol; 2012 Oct; 10(10):1162-8; quiz e87. PubMed ID: 22796457
    [Abstract] [Full Text] [Related]

  • 17. Hepatic histology in obese patients undergoing bariatric surgery.
    Machado M, Marques-Vidal P, Cortez-Pinto H.
    J Hepatol; 2006 Oct; 45(4):600-6. PubMed ID: 16899321
    [Abstract] [Full Text] [Related]

  • 18. Non-alcoholic steatohepatitis in children.
    Nanda K.
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [Abstract] [Full Text] [Related]

  • 19. Natural history of nonalcoholic steatohepatitis.
    Liou I, Kowdley KV.
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S11-6. PubMed ID: 16540761
    [Abstract] [Full Text] [Related]

  • 20. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years.
    Wong VW, Wong GL, Choi PC, Chan AW, Li MK, Chan HY, Chim AM, Yu J, Sung JJ, Chan HL.
    Gut; 2010 Jul; 59(7):969-74. PubMed ID: 20581244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.